The newly approved device is much smaller than previous offerings, helping operators capture 3D images during structural heart evaluations. 

The FDA’s final decision was based largely on positive results from the ADVENT clinical trial, which compared treatment with the Farapulse PFA System to the current standard of care.

Eckert & Ziegler and Nucleus RadioPharma have signed an agreement to address the increasing demand for Lu-177 and Ac-225.

AHIP and the Blue Cross Blue Shield Association recently polled 21 U.S. health insurance providers about their experiences with the landmark legislation.

Conversations last 10 minutes or less, with specialists providing a preliminary interpretation of imaging findings in conjunction with smoking cessation counseling. 

The Centers for Medicare & Medicaid Services has launched a website breaking down the basics of value-based care. The site is suitable for educating healthcare consumers and professionals alike.

Anemic post-pandemic operating margins probably won’t cause nonprofit hospitals to suffer credit downgrades “en masse.”

The German manufacturer and Canadian drug developer are partnering to address the supply crunch of radioisotopes.

The University of Oklahoma Health has earned a $3 million grant from the National Cancer Institute for this project.

As Congress negotiates reimbursement rates, Rick Pollack, president and CEO of the American Hospital Association, is urging lawmakers to halt any further payment cuts that could compromise patient care and hospital services nationwide.